W
MRNA icon

WealthCollab’s Moderna MRNA Stock Holding History

WealthCollab’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Hold
200
– – 0.01% 502
2026
Q1 		$10.2K Hold
200
– – ﹤0.01% 549
2025
Q4 		$5.9K Hold
200
– – ﹤0.01% 683
2025
Q3 		$5.17K Hold
200
– – ﹤0.01% 670
2025
Q2 		$5.52K Hold
200
– – ﹤0.01% 612
2025
Q1 		$5.67K Hold
200
– – ﹤0.01% 593
2024
Q4 		$8.32K Hold
200
– – 0.01% 488
2024
Q3 		$13.4K Hold
200
– – 0.01% 401
2024
Q2 		$23.8K Hold
200
– – 0.02% 260
2024
Q1 		$21.3K Sell
200
-29
-13% -$2.92K 0.02% 293
2023
Q4 		$22.8K Buy
+229
New +$19.3K 0.02% 253

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

WealthCollab's MRNA Position: Q2 2026 in Review

WealthCollab held its Moderna (MRNA) position steady in Q2 2026 at 200 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #502.

WealthCollab first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $23.8K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • WealthCollab held 200 shares of Moderna worth $14K as of Q2 2026.
  • WealthCollab left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of WealthCollab's portfolio in Q2 2026, its #502 holding.
  • WealthCollab first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Moderna position peaked at $23.8K in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.